PRESS RELEASE published on 07/25/2024 at 18:00, 2 years 3 months ago Financing resources reinforced through a new syndicated loan - Medium-term financing secured and debt maturity extended Groupe Bastide secures new €375M financing contract replacing existing loans, includes syndicated loan, revolving credit. Loan terms, cost of debt, CSR factors detailed. Natixis, Société Générale, BNP lead. Funding from banks, investors. Debt reduction plan confirmed Debt Management Syndicated Loan Groupe Bastide Financing Contract Loan Terms
BRIEF published on 07/04/2024 at 18:35, 2 years 3 months ago BASTIDE: Number of shares and voting rights as of June 30, 2024 Voting Rights Actions AMF Bastide June 2024
BRIEF published on 06/04/2024 at 18:20, 2 years 4 months ago Number of shares and voting rights as of May 31, 2024 Voting Rights Actions Finance Bastide
BRIEF published on 05/15/2024 at 18:05, 2 years 5 months ago Bastide announces accelerated organic growth and the sale of its activities in Switzerland Financial Results Organic Growth Transfer Bastide Home Health
PRESS RELEASE published on 05/15/2024 at 18:00, 2 years 5 months ago Organic growth accelerated in third quarter 2023-2024 up 7.5% and sale of Homecare business in Switzerland in progress Groupe Bastide reports +8.2% revenue growth in Q3 2023-2024. Sale of Swiss subsidiaries in progress. Focus on organic growth and strategic asset divestments Revenue Growth Organic Growth Groupe Bastide Asset Divestments Swiss Subsidiaries
BRIEF published on 05/03/2024 at 18:05, 2 years 5 months ago Bastide Le Confort Médical announces its capital in voting rights as of April 30, 2024 Voting Rights Financial Markets Preference Shares Ordinary Actions Bastide
BRIEF published on 04/30/2024 at 15:50, 2 years 5 months ago Groupe Bastide webinar for shareholders and investors on May 22, 2024 Investors Webinar Strategy Questions Bastide Group
BRIEF published on 04/08/2024 at 18:05, 2 years 6 months ago Bastide wins a major respiratory assistance contract in the United Kingdom United Kingdom NHS Bastide Respiratory Support Oxygen Therapy
PRESS RELEASE published on 04/08/2024 at 18:00, 2 years 6 months ago Respiratory care therapy: Bastide wins new United Kingdom region - EUR 10 million/year contract for a minimum of seven years Bastide appointed exclusive respiratory care operator in East of England by NHS, bringing €10 million yearly revenue. Further expansion expected Expansion NHS Bastide Respiratory Care East Of England
Published on 10/24/2026 at 00:04, 1 day 19 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 1 day 19 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 1 day 21 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 3 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/24/2026 at 23:44, 20 hours 38 minutes ago EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH
Published on 10/24/2026 at 14:15, 1 day 5 hours ago Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
Published on 10/24/2026 at 06:30, 1 day 12 hours ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 2 days ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 2 days 1 hour ago BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 20:33, 1 day 22 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 1 hour ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 1 hour ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 3 days 1 hour ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
